Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy-Reference-Cited by-同舟云学术

Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy

Published:2024-02 Issue:2 Volume:5 Page:101389
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Feng Huijie,Clatot Jerome,Kaneko Keisuke,Flores-Mendez Marco,Wengert Eric R.,Koutcher Carly,Hoddeson Emily,Lopez Emily,Lee Demetrius,Arias Leroy,Liang Qiansheng,Zhang Xiaohong,Somarowthu Ala,Covarrubias Manuel,Gunthorpe Martin J.,Large Charles H.,Akizu Naiara,Goldberg Ethan M.^ORCID

Publisher

Elsevier BV

Reference63 articles.

1. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations;Nascimento;Epileptic Disord.,2016

2. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy;Muona;Nat. Genet.,2015

3. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K(+) channel properties;Oliver;Ann. Neurol.,2017

4. Progressive Myoclonus Epilepsies;Kälviäinen;Semin. Neurol.,2015

5. The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy;Orsini;Seizure,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of hypoactive parvalbumin-positive fast-spiking interneuron restores dentate inhibition to prevent epileptiform activity in the mouse intrahippocampal kainate model of temporal lobe epilepsy;2024-04-08

2. The binding and mechanism of a positive allosteric modulator of Kv3 channels;Nature Communications;2024-03-21